30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Propanc Biopharma Inc (PPCH)

Stock chart
Ticker: PPCH


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nathanielsz James Andrew
Chief Executive Officer
1 sale — total 4,983 USD
Sale 5 Jul 2013
Value US$509,011.42 | Price 354.31 | Shares 36,654
Sale 23 Jan 2013
Value US$1,743,010.33 | Price 294.61 | Shares 38,066
Sale 13 Dec 2012
Value US$1,100.00 | Price 0.20 | Shares 5,500
Sale 14 Sep 2012
Value US$1,000.00 | Price 0.20 | Shares 5,000
Sale 4 Sep 2012
Value US$50,000.00 | Price 0.20 | Shares 250,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2015-01-13 2013-07-05 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
36,654 +47.1%
354.31
US$509,011
36,654 +47.1% 354.31 US$509,011
2015-01-13 2013-01-23 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
38,066 +46.3%
294.61
US$1,743,010
38,066 +46.3% 294.61 US$1,743,010
2015-01-13 2012-12-13 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
68,722 +47.9%
101.85
US$2,859,180
68,722 +47.9% 101.85 US$2,859,180
2015-01-13 2012-09-14 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
5,000 -0.1%
0.20
US$1,000
5,000 -0.1% 0.20 US$1,000
2015-01-13 2012-09-04 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
250,000 -2.5%
0.20
US$50,000
250,000 -2.5% 0.20 US$50,000
Explore more

More insider trading research around Propanc Biopharma Inc